References

Global cancer statistics, 2002

2005 · External reference

Unresolved reference

External reference

Clinical outcome and survival after esophagectomy for carcinoma in elderly patients

10.1046/j.1442-2050.2003.00300.x · 2003 · External reference

Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: A population-based analysis of elderly patients

10.1200/jco.2006.09.7931 · 2007 · External reference

Esophageal resection in elderly esophageal carcinoma patients: Improvement in postoperative complications

10.1016/s0003-4975(00)02333-x · 2001 · External reference

Esophageal resection for carcinoma in patients older than 70 years

10.1007/bf02557376 · 2002 · External reference

Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer

10.1097/01.sla.0000143123.24556.1c · 2004 · External reference

Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

10.1001/jama.281.17.1623 · 1999 · External reference

Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older

10.1111/j.1442-2050.2009.01014.x · 2010 · External reference

Combined modality chemoradiation in elderly oesophageal cancer patients

10.1038/sj.bjc.6603821 · 2007 · External reference

Erlotinib and radiation therapy for elderly patients with esophageal cancer - clinical and correlative results from a prospective multicenter phase 2 trial

10.1159/000351617 · 2013 · External reference

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group (ECOG) results of protocol E1293

10.1007/bf02993858 · 1996 · External reference

Docetaxel in the treatment of esophageal cancer

10.1053/j.seminoncol.2005.04.005 · 2005 · External reference

Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells

1996 · External reference

Radiosensitization of colon cancer cell lines by docetaxel: Mechanisms of action

10.3727/0965040041791455 · 2004 · External reference

Phase I study of docetaxel with concomitant thoracic radiation therapy

10.1200/jco.1998.16.1.159 · 1998 · External reference

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial

10.1016/s0959-8049(97)10101-0 · 1998 · External reference

Radiotherapy with concomitant weekly docetaxel for stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC phase II trial

10.1016/s0360-3016(03)01370-1 · 2004 · External reference

Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck

10.1007/s10147-003-0375-z · 2004 · External reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

10.1093/jnci/92.3.205 · 2000 · External reference

Guidelines for diagnosis and treatment of carcinoma of the esophagus; April 2007 edition: Part I. Edited by the Japan Esophageal Society

10.1007/s10388-008-0151-2 · 2008 · External reference

Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906)

10.1016/j.ijrobp.2010.06.033 · 2011 · External reference

Preoperative chemoradiotherapy for esophageal or junctional cancer

10.1056/nejmoa1112088 · 2012 · External reference

A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer

10.1097/coc.0b013e3180ca7c84 · 2007 · External reference

INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy

10.1200/jco.2002.20.5.1167 · 2002 · External reference

Definitive chemoradiation therapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer: A phase 2 trial (KDOG 0501-P2)

10.1016/j.ijrobp.2014.03.030 · 2014 · External reference